Rigorous Science
We combine deep research with creative formulation design to develop targeted, effective treatments that address critical unmet menopause needs in women's health.
450M+
Women worldwide with unmet needs
An opportunity for accredited investors to share ownership in a breakthrough pharmaceutical to treat key issues in menopause and diminished libido.
Advancing the future of cures for women's health
Millions of women per year become candidates for help as menopause inevitably arrives. In human terms, and in business terms, a vast market exists for improved help.


We combine deep research with creative formulation design to develop targeted, effective treatments that address critical unmet menopause needs in women's health.
450M+
Women worldwide with unmet needs
Our platform leverages advanced delivery systems and novel compounds to create therapies that are powerful, purposeful, and designed for real patients.
100%
Women-focused therapeutic pipeline
Every innovation begins with women — their biology, their unmet needs, their potential. We're shaping therapies that elevate care and transform lives.
1.3M
Women entering menopause annually (US)
The need is real
450M+
Women worldwide with perimenopausal or postmenopausal symptoms
Source: World Economic Forum & McKinsey Health Institute, 2024
55M
Women in the U.S. in the age range for menopause
Source: U.S. Census Bureau
1.3M
Women in the U.S. become menopausal each year
Source: StatPearls, National Library of Medicine
Discover how JASTLabs innovation in the treatment of menopause addresses a global unmet need.